Medicare Enrolled
Dr. Jessica Hals, D.O.
Hematology & Oncology · Weatherford, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Hals from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hals? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hals
Dr. Jessica Hals is a hematology & oncology in Weatherford, TX, with 19 years in practice. Based on federal Medicare data, Dr. Hals performed 5,489 Medicare services across 802 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hals received a total of $11,139 from 91 pharmaceutical and/or device companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hals is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 40% volume in TX$ $11,139 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,489
Medicare services
Top 40% in TX for hematology & oncology
802
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~289 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,560 | $18 | $56 |
| Epoetin alfa injection (Retacrit) for anemia | 1,330 | $6 | $19 |
| Dexamethasone injection (steroid) | 1,091 | $0 | $1 |
| Office visit, established patient (30-39 min) | 251 | $83 | $318 |
| Anti-nausea injection (Aloxi/palonosetron) | 250 | $1 | $11 |
| Blood draw (venipuncture) | 236 | $8 | $67 |
| Complete blood count (CBC) with differential | 196 | $8 | $100 |
| Comprehensive metabolic blood panel | 155 | $10 | $100 |
| Injection of additional new drug or substance into vein | 118 | $12 | $94 |
| Drug injection, under skin or into muscle | 88 | $10 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 72 | $99 | $448 |
| Office visit, established patient (20-29 min) | 70 | $61 | $203 |
| Magnesium level test | 26 | $6 | $75 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 24 | $48 | $160 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 22 | $1 | $4 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.4% high complexity
82.5% medium
17.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$11,139
Total received (2018-2024)
Avg $1,857/year across 6 years
Top 30% in TX for hematology & oncology
91
Companies
567
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,664 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$476 (4.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,736
2023$4,343
2022$2,787
2021$50
2019$1,315
2018$909
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$731
Novartis Pharmaceuticals Corporation
$696
Janssen Biotech, Inc.
$641
Merck Sharp & Dohme LLC
$487
E.R. Squibb & Sons, L.L.C.
$486
PFIZER INC.
$480
Amgen Inc.
$372
Genentech USA, Inc.
$343
Astellas Pharma US Inc
$337
Lilly USA, LLC
$334
Celgene Corporation
$309
Karyopharm Therapeutics Inc.
$296
Daiichi Sankyo Inc.
$286
AVEO Pharmaceuticals, Inc.
$224
GlaxoSmithKline, LLC.
$223
Incyte Corporation
$216
GENZYME CORPORATION
$214
Eisai Inc.
$201
SOBI, INC
$186
US Oncology Corporate, Inc.
$179
JAZZ PHARMACEUTICALS INC.
$169
Seagen Inc.
$167
Takeda Pharmaceuticals U.S.A., Inc.
$165
Taiho Oncology, Inc.
$155
Ipsen Biopharmaceuticals, Inc
$155
Pacira Pharmaceuticals Incorporated
$125
BeiGene USA, Inc.
$111
Bayer Healthcare Pharmaceuticals Inc.
$103
Gilead Sciences, Inc.
$95
Pharmacosmos Therapeutics Inc.
$93
Intuitive Surgical, Inc.
$92
Regeneron Healthcare Solutions, Inc.
$91
Merck Sharp & Dohme Corporation
$91
Sirtex Medical Inc
$89
ABBVIE INC.
$88
Exelixis Inc.
$85
ADC Therapeutics America, Inc.
$82
MorphoSys, US Inc.
$82
Seattle Genetics, Inc.
$81
TerSera Therapeutics LLC
$75
EMD Serono, Inc.
$70
Puma Biotechnology, Inc.
$66
ERBE USA Inc
$66
Rigel Pharmaceuticals, Inc.
$62
Epizyme, Inc.,
$61
Bayer HealthCare Pharmaceuticals Inc.
$60
PUMA BIOTECHNOLOGY, INC.
$58
EISAI INC.
$58
Kite Pharma, Inc.
$55
ARRAY BIOPHARMA INC
$54
Pharmacyclics LLC, An AbbVie Company
$53
Agios Pharmaceuticals, Inc.
$53
Sumitomo Pharma America, Inc.
$50
AbbVie, Inc.
$46
Coherus Biosciences Inc.
$46
PharmaEssentia USA Corporation
$45
TAIHO ONCOLOGY, INC.
$44
CTI BioPharma Corp.
$43
TESARO, Inc.
$41
Heron Therapeutics, Inc.
$35
Kyowa Kirin, Inc.
$33
Clovis Oncology, Inc.
$32
Amneal Pharmaceuticals LLC
$31
Stemline Therapeutics Inc.
$31
Foundation Medicine, Inc.
$30
Tempus AI, Inc
$29
Pharmacyclics LLC, an AbbVie Company
$28
Mirati Therapeutics, Inc.
$26
Genmab U.S., Inc.
$25
Nestle HealthCare Nutrition Inc.
$24
Blueprint Medicines Corporation
$24
Fennec Pharmaceuticals, Inc.
$22
Acrotech Biopharma Inc.
$21
Sun Pharmaceutical Industries Inc.
$21
Alexion Pharmaceuticals, Inc.
$20
SERVIER PHARMACEUTICALS LLC
$19
G1 Therapeutics, Inc.
$18
Verastem, Inc.
$18
Deciphera Pharmaceuticals Inc.
$17
Janssen Pharmaceuticals, Inc
$16
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Aveo Pharmaceuticals, Inc.
$16
SpringWorks Therapeutics, Inc.
$15
Dova Pharmaceuticals
$15
Tolmar, Inc.
$15
TOLMAR Pharmaceuticals, Inc.
$14
TG Therapeutics, Inc.
$13
MEDIVATION FIELD SOLUTIONS LLC
$13
Shield Therapeutics Inc
$13
Blue Earth Diagnostics Limited
$12
Acrotech Biopharma LLC
$12
Top 3 companies account for 18.6% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADAKVEO · ADCETRIS · ALIMTA · AVASTIN · AYVAKIT · Abraxane · Alecensa · Aliqopa · Aranesp · Axumin · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · CABLIVI · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DAURISMO · DOPTELET · Da Vinci Surgical System · Doptelet · ELAHERE · ELIGARD · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · ENJAYMO · ERBITUX · ERLEADA · EXKIVITY · Enhertu · Epkinly · Erbe CRYO2 · Erivedge · Erleada · Exparel · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · GILOTRIF · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LILETTA · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Pedmark · Perjeta · Pomalyst · Poteligeo · QINLOCK · REBLOZYL · RETEVMO · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TUKYSA · Tavalisse · Tecentriq · Tibsovo · UKONIQ · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $203 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
5
Per 100K population
3.2
County median income
$102,099
Nearest hospital
MEDICAL CITY WEATHERFORD
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hals is a mixed practice specialist, with moderate Medicare volume, and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hals experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Hals performed 1,560 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hals receive payments from pharmaceutical companies?
Yes. Dr. Hals received a total of $11,139 from 91 companies across 567 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hals's costs compare to other hematology & oncologys in Weatherford?
Dr. Hals's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hals) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Weatherford
Browse hematology & oncologys in Weatherford ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in TX
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in TX
Which TX hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology